このページの翻訳は実験的なもので、現在開発中です。お待ちしております！
Boston Scientific 過去の業績
過去 基準チェック /46
Boston Scientificの収益は年間平均-23.2%の割合で減少していますが、 Medical Equipment業界の収益は年間 増加しています。収益は年間8.7% 7.9%割合で 増加しています。 Boston Scientificの自己資本利益率は8.8%であり、純利益率は12%です。
主要情報
-21.4%
収益成長率
-22.7%
EPS成長率
| Medical Equipment 業界の成長 | 8.9% |
| 収益成長率 | 8.5% |
| 株主資本利益率 | 8.8% |
| ネット・マージン | 12.0% |
| 前回の決算情報 | 30 Jun 2024 |
最近の業績更新
Recent updates
Boston Scientific Q2 Earnings Preview: Can The Rally Continue?
Jul 17Here's Why We Think Boston Scientific (NYSE:BSX) Is Well Worth Watching
Jul 05
Should You Investigate Boston Scientific Corporation (NYSE:BSX) At US$77.00?
Jun 21Boston Scientific Has Become A Standout Growth Story In Med-Tech
Jun 13Why We're Not Concerned About Boston Scientific Corporation's (NYSE:BSX) Share Price
Jun 08Is Boston Scientific (NYSE:BSX) Using Too Much Debt?
May 10Boston Scientific (NYSE:BSX) Is Reinvesting At Lower Rates Of Return
Apr 22Boston Scientific: Implications Of The Axonics-Medtronic Patent Clash
Apr 05A Look At The Fair Value Of Boston Scientific Corporation (NYSE:BSX)
Mar 26We Ran A Stock Scan For Earnings Growth And Boston Scientific (NYSE:BSX) Passed With Ease
Feb 29What You Can Learn From Boston Scientific Corporation's (NYSE:BSX) P/E
Feb 15Is Boston Scientific (NYSE:BSX) A Risky Investment?
Feb 02Boston Scientific (NYSE:BSX) Could Be Struggling To Allocate Capital
Jan 19Boston Scientific: Portfolio Updates Driving Top-Line Growth
Jan 17Boston Scientific: Continued M&A Drives More Growth
Jan 10Is Boston Scientific Corporation (NYSE:BSX) Worth US$56.1 Based On Its Intrinsic Value?
Dec 04Does Boston Scientific (NYSE:BSX) Have A Healthy Balance Sheet?
Nov 03Boston Scientific: Delivering Strong Growth, But Sector Derating Is A Big Issue
Oct 30ADVENT Offers Up An Early Present For Boston Scientific Investors
Aug 28Estimating The Fair Value Of Boston Scientific Corporation (NYSE:BSX)
Aug 24Boston Scientific (NYSE:BSX) Seems To Use Debt Quite Sensibly
Jul 25Boston Scientific Remains Operationally Sound But May Have Limited Upside
Jul 14Investors Could Be Concerned With Boston Scientific's (NYSE:BSX) Returns On Capital
Jul 10Boston Scientific Corporation (NYSE:BSX) Shares Could Be 29% Above Their Intrinsic Value Estimate
May 21Here's Why Boston Scientific (NYSE:BSX) Can Manage Its Debt Responsibly
Apr 18Returns On Capital At Boston Scientific (NYSE:BSX) Paint A Concerning Picture
Apr 03Boston Scientific Stands Out With Strong, Diversified Growth Profile
Feb 15収支内訳
収支内訳
Boston Scientific の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。
収益と収入の歴史
| 日付 | 収益 | 収益 | G+A経費 | 研究開発費 |
|---|---|---|---|---|
| 30 Jun 24 | 15,229 | 1,828 | 5,430 | 1,468 |
| 31 Mar 24 | 14,707 | 1,765 | 5,339 | 1,443 |
| 31 Dec 23 | 14,240 | 1,570 | 5,190 | 1,414 |
| 30 Sep 23 | 13,757 | 1,191 | 4,974 | 1,381 |
| 30 Jun 23 | 13,400 | 861 | 4,865 | 1,364 |
| 31 Mar 23 | 13,045 | 846 | 4,675 | 1,341 |
| 31 Dec 22 | 12,682 | 642 | 4,520 | 1,323 |
| 30 Sep 22 | 12,567 | 596 | 4,510 | 1,313 |
| 30 Jun 22 | 12,329 | 828 | 4,445 | 1,284 |
| 31 Mar 22 | 12,162 | 754 | 4,400 | 1,247 |
| 31 Dec 21 | 11,888 | 985 | 4,359 | 1,204 |
| 30 Sep 21 | 11,470 | 1,101 | 4,182 | 1,166 |
| 30 Jun 21 | 11,196 | 526 | 4,099 | 1,171 |
| 31 Mar 21 | 10,122 | 201 | 3,777 | 1,115 |
| 31 Dec 20 | 9,913 | -115 | 3,787 | 1,143 |
| 30 Sep 20 | 10,108 | 3,685 | 3,864 | 1,165 |
| 30 Jun 20 | 10,157 | 3,980 | 3,892 | 1,157 |
| 31 Mar 20 | 10,785 | 4,287 | 4,062 | 1,194 |
| 31 Dec 19 | 10,735 | 4,700 | 3,928 | 1,174 |
| 30 Sep 19 | 10,392 | 1,090 | 3,790 | 1,154 |
| 30 Jun 19 | 10,077 | 1,396 | 3,648 | 1,136 |
| 31 Mar 19 | 9,937 | 1,797 | 3,566 | 1,132 |
| 31 Dec 18 | 9,823 | 1,671 | 3,557 | 1,113 |
| 30 Sep 18 | 9,670 | 670 | 3,498 | 1,088 |
| 30 Jun 18 | 9,500 | 521 | 3,424 | 1,053 |
| 31 Mar 18 | 9,267 | 112 | 3,350 | 1,023 |
| 31 Dec 17 | 9,048 | 104 | 3,281 | 997 |
| 30 Sep 17 | 8,831 | 843 | 3,227 | 990 |
| 30 Jun 17 | 8,714 | 788 | 3,199 | 969 |
| 31 Mar 17 | 8,582 | 435 | 3,163 | 945 |
| 31 Dec 16 | 8,386 | 347 | 3,083 | 920 |
| 30 Sep 16 | 8,095 | 81 | 3,029 | 908 |
| 30 Jun 16 | 7,878 | -345 | 2,979 | 895 |
| 31 Mar 16 | 7,595 | -36 | 2,898 | 894 |
| 31 Dec 15 | 7,477 | -239 | 2,847 | 876 |
| 30 Sep 15 | 7,314 | -396 | 2,819 | 840 |
| 30 Jun 15 | 7,272 | -155 | 2,836 | 832 |
| 31 Mar 15 | 7,302 | -253 | 2,883 | 818 |
| 31 Dec 14 | 7,308 | -119 | 2,878 | 817 |
| 30 Sep 14 | 7,258 | 288 | 2,849 | 826 |
| 30 Jun 14 | 7,147 | 240 | 2,766 | 831 |
| 31 Mar 14 | 7,083 | 366 | 2,680 | 848 |
| 31 Dec 13 | 7,070 | -121 | 2,651 | 861 |
| 30 Sep 13 | 7,126 | -168 | 2,566 | 882 |
質の高い収益: BSXは 高品質の収益 を持っています。
利益率の向上: BSXの現在の純利益率 (12%)は、昨年(6.5%)よりも高くなっています。
フリー・キャッシュフローと収益の比較
過去の収益成長分析
収益動向: BSXの収益は過去 5 年間で年間23.2%減少しました。
成長の加速: BSXの過去 1 年間の収益成長率 ( 108.6% ) は、5 年間の平均 ( 年間-23.2%を上回っています。
収益対業界: BSXの過去 1 年間の収益成長率 ( 108.6% ) はMedical Equipment業界2.4%を上回りました。
株主資本利益率
高いROE: BSXの 自己資本利益率 ( 8.8% ) は 低い とみなされます。